Overview

Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study sought to determine whether terbogrel was an effective treatment for primary pulmonary hypertension (PPH) by comparing its efficacy and safety to that of placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim